Carson Allaria Wealth Management, Ltd. Sarepta Therapeutics, Inc. Transaction History
Carson Allaria Wealth Management, Ltd.
- $180 Million
- Q2 2025
A detailed history of Carson Allaria Wealth Management, Ltd. transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Carson Allaria Wealth Management, Ltd. holds 25 shares of SRPT stock, worth $455. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25
Previous 25
-0.0%
Holding current value
$455
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding SRPT
# of Institutions
486Shares Held
91.4MCall Options Held
1.39MPut Options Held
1.15M-
Black Rock Inc. New York, NY10.3MShares$188 Million0.04% of portfolio
-
Capital International Investors Los Angeles, CA9.06MShares$165 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.03MShares$165 Million0.01% of portfolio
-
State Street Corp Boston, MA4.07MShares$74.2 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X03.36MShares$61.3 Million0.12% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $1.6B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...